Integrin Receptor Antagonist
- Name
- Integrin Receptor Antagonist
- Accession Number
- DBCAT003280 (DBCAT004289)
- Description
Not Available
- Drugs
Drug Drug Description Natalizumab A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. Vedolizumab An integrin blocker and anti-inflammatory agent used to manage ulcerative colitis and Crohn's disease in adults. Etrolizumab A humanized IgG1κ anti-β7 integrin subunit monoclonal antibody under investigation for use in ulcerative colitis and Crohn's disease. - Drugs & Drug Targets